During the past decade, Dr. Thomas Kaercher conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dr. Thomas Kaercher" are "Dry Eye Syndromes" (1 trials) and "Viral Conjunctivitis" (1 trials). Many other conditions were trialed in "Dr. Thomas Kaercher" in a lesser frequency.

Most popular intervention types in "Dr. Thomas Kaercher" are "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "NovaTears® Eye Drops" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dr. Thomas Kaercher" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Dr. Thomas Kaercher". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Dr. Thomas Kaercher, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dr. Thomas Kaercher, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".